Company Profile for Jerini AG.Jerini AG is a drug discovery and development company based in Berlin, Germany. The company discovers and develops drugs taking advantage of the company's proprietary Peptides-To-Drugs (P2D P2D Point to Discover P2D Power-Dependent S-Parameter P2D PointLineCad 2D Drawing - 2D Document (File Extension) P2D Packed-To-Decimal (function for number format conversion) ) platform. P2D enables Jerini to address difficult targets not amenable to conventional approaches. Targets are selected to achieve an optimal synergy between medical need and P2D. Jerini's lead product Icatibant is currently in pivotal registration studies in US and Canada in the indication hereditary angioedema Hereditary angioedema A complement deficiency characterized by lymphatic vessel blockages that cause temporary swelling (edema) of areas of the skin, mucous membranes, and, sometimes, internal organs. Mentioned in: Complement Deficiencies . The company aims for first market approval in 2006/2007. Jerini will develop Icatibant in further indications such as severe burn injuries and postherpetic pain. Moreover, Jerini has several compounds in the preclinical stages for evaluating the treatment of macular degeneration macular degeneration, eye disorder causing loss of central vision. The affected area, the macula, lies at the back of the retina and is the part that produces the sharpest vision. , cancer and inflammatory diseases Noun 1. inflammatory disease - a disease characterized by inflammation disease - an impairment of health or a condition of abnormal functioning NEC, necrotizing enterocolitis - an acute inflammatory disease occurring in the intestines of premature infants; . The company is supported by an international consortium of investors and has raised over EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 55 million since 2000. Jerini's long term goal is to become a globally acting fully integrated pharma company. The company will market products on its own in niche indications, and will partner its products in larger indications. Jerini's wholly-owned subsidiary, JPT JPT Journal of Petroleum Technology JPT Java Power Tools JPT JP Taravella High School (Coral Springs, Florida) JPT Joint Project Team JPT Jet Pipe Temperature (aeronautics) JPT Joint Planning Team Peptide Technologies GmbH, is a peptide-based service provider for innovative peptide-related services for all fields of biomedical research Biomedical research (or experimental medicine), in general simply known as medical research, is the basic research or applied research conducted to aid the body of knowledge in the field of medicine. .
Company: Jerini AG
Headquarters Address: Invalidenstr. 130
10115 Berlin
Germany
Main Telephone: +49-30-978 93 100
Website: www.jerini.com
Type of Organization: Private
Industry: Health: Biotechnology
Key Executives: CEO: Jens Schneider-Mergener
COO: Adi Hoess
Head R&D: Jochen Knolle
Public Relations
Contact: Helena Dreznjak
Phone: +49-30+978 93 118
Email: h.dreznjak@jerini.com
Investor Relations
Contact: Stacy Wiedenmann
Phone: +49-30+978 93 285
Email: wiedenmann@jerini.com
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion